What is 9th Circuit Court of Appeals? Order that reinstates Trump can keep National Guard in LA
The 9th Circuit Court, based in San Francisco, is one of the most powerful federal appeals courts in the country. It covers nine western states, including California. The three-judge panel reviewing this case includes two Trump appointees and one appointed by President Biden. A full hearing is set for Tuesday.
The decision followed a 36-page ruling by U.S. District Judge Charles Breyer earlier that day, who said Trump had overstepped his legal authority. Breyer wrote that Trump's move to federalise the Guard during protests over immigration raids was unlawful, saying the action 'violated the 10th Amendment to the United States Constitution.'
'The protests in Los Angeles fall far short of 'rebellion,'' Breyer wrote. 'The evidence is overwhelming that protesters gathered to protest a single issue—the immigration raids.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
33 minutes ago
- Business Standard
US aid cuts pause HIV vaccine research in S Africa, to have global impact
Just a week had remained before scientists in South Africa were to begin clinical trials of an HIV vaccine, and hopes were high for another step toward limiting one of history's deadliest pandemics. Then the email arrived. Stop all work, it said. The United States under the Trump administration was withdrawing all its funding. The news devastated the researchers, who live and work in a region where more people live with HIV than anywhere else in the world. Their research project, called BRILLIANT, was meant to be the latest to draw on the region's genetic diversity and deep expertise in the hope of benefiting people everywhere. But the $46 million from the US for the project was disappearing, part of the dismantling of foreign aid by the world's biggest donor earlier this year as President Donald Trump announced a focus on priorities at home. South Africa hit hard by aid cuts South Africa has been hit especially hard because of Trump's baseless claims about the targeting of the country's white Afrikaner minority. The country had been receiving about $400 million a year via USAID and the HIV-focused PEPFAR. Now that's gone. Glenda Grey, who heads the Brilliant program, said the African continent has been vital to the development of HIV medication, and the US cuts threaten its capability to do such work in the future. Significant advances have included clinical trials for lenacapavir, the world's only twice-a-year shot to prevent HIV, recently approved for use by the US Food and Drug Administration. One study to show its efficacy involved young South Africans. We do the trials better, faster and cheaper than anywhere else in the world, and so without South Africa as part of these programs, the world, in my opinion, is much poorer, Gray said. She noted that during the urgency of the COVID-19 pandemic, South Africa played a crucial role by testing the Johnson & Johnson and Novavax vaccines, and South African scientists' genomic surveillance led to the identification of an important variant. Labs empty and thousands are laid off A team of researchers at the University of the Witwatersrand has been part of the unit developing the HIV vaccines for the trials. Inside the Wits laboratory, technician Nozipho Mlotshwa was among the young people in white gowns working on samples, but she may soon be out of a job. Her position is grant-funded. She uses her salary to support her family and fund her studies in a country where youth unemployment hovers around 46 per cent. It's very sad and devastating, honestly," she said of the US cuts and overall uncertainty. We'll also miss out collaborating with other scientists across the continent. Professor Abdullah Ely leads the team of researchers. He said the work had promising results indicating that the vaccines were producing an immune response. But now that momentum, he said, has all kind of had to come to a halt. The BRILLIANT program is scrambling to find money to save the project. The purchase of key equipment has stopped. South Africa's health department says about 100 researchers for that program and others related to HIV have been laid off. Funding for postdoctoral students involved in experiments for the projects is at risk. South Africa's government has estimated that universities and science councils could lose about $107 million in US research funding over the next five years due to the aid cuts, which affect not only work on HIV but also tuberculosis another disease with a high number of cases in the country. Less money, and less data on what's affected South Africa's government has said it will be very difficult to find funding to replace the US support. And now the number of HIV infections will grow. Medication is more difficult to obtain. At least 8,000 health workers in South Africa's HIV programme have already been laid off, the government has said. Also gone are the data collectors who tracked patients and their care, as well as HIV counselors who could reach vulnerable patients in rural communities. For researchers, Universities South Africa, an umbrella body, has applied to the national treasury for over $110 million for projects at some of the largest schools. During a visit to South Africa in June, UNAIDS executive director Winnie Byanyima was well aware of the stakes, and the lives at risk, as research and health care struggle in South Africa and across Africa at large. Other countries that were highly dependent on US funding including Zambia, Nigeria, Burundi and Ivory Coast are already increasing their own resources, she said. But let's be clear, what they are putting down will not be funding in the same way that the American resources were funding," Byanyima said.
Time of India
34 minutes ago
- Time of India
Trade war: Donald Trump threatens 20%–50% tariff on 23 nations
US President Donald Trump has sent letters to 23 trading partners this week, including Canada, Japan, Brazil, and others — threatening blanket import tariffs ranging from 20% to 50%. The move, part of a renewed aggressive trade stance, also includes a 50% duty on copper imports. The letters outline that the proposed 30% general tariff would be in addition to existing levies — such as 50% on steel and aluminum and 25% on autos, which will remain in place. Countries have until August 1 to negotiate individual trade deals to avoid the hikes. This marks a return to Trump's hardline approach seen earlier this year, when a similar round of tariff announcements jolted global markets before being postponed. EU and Mexico condemn proposed tariffs as unfair Earlier on Saturday, Trump warned he would impose a 30% tariff on imports from the European Union and Mexico starting August 1, after trade talks with both sides failed to reach a full agreement. The announcement, shared through letters posted on Trump's Truth Social account, marks a sharp escalation in trade tensions. It has alarmed US allies and shaken investor confidence. Despite global pushback, Trump appears undeterred, buoyed by a strong US economy and record stock market highs. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Providers are furious: Internet access without a subscription! Techno Mag Learn More Undo In his letter to the European Commission, Trump demanded that the EU remove all tariffs on US goods, claiming the bloc must help reduce America's trade deficit. Both the EU and Mexico, key US trade partners, condemned the proposed tariffs as unfair and disruptive. Despite the warning, they expressed willingness to continue negotiations in hopes of reaching a broader deal before the deadline. Mexican President Claudia Sheinbaum said she remained confident that an agreement could still be finalised. "I've always said that in these cases, what you have to do is keep a cool head to face any problem," Sheinbaum said. "We're also clear on what we can work with the United States government on, and we're clear on what we can't. And there's something that's never negotiable: the sovereignty of our country," she added. European Commission President Ursula von der Leyen said that, "The European Union will allow complete, open Market Access to the United States, with no Tariff being charged to us, in an attempt to reduce the large Trade Deficit," he wrote. She also warned that the 30% tariffs "would disrupt essential transatlantic supply chains, to the detriment of businesses, consumers and patients on both sides of the Atlantic." Trump has so far only reached framework trade deals with a few countries like the UK, China, and Vietnam. Talks with other major partners remain ongoing. Mexican tariff proposal below Canadian rate The proposed tariff rate for Mexico is less than Canada's 35%, with both nations' correspondence mentioning fentanyl trafficking, despite official statistics indicating substantially higher seizures at the Mexican frontier compared to the Canadian border, according to Reuters. "Mexico has been helping me secure the border, BUT, what Mexico has done, is not enough. Mexico still has not stopped the Cartels who are trying to turn all of North America into a Narco-Trafficking Playground," Trump wrote. China remains the primary supplier of precursor chemicals for fentanyl production. Fentanyl to fix trade and toxins According to US authorities, just 0.2% of all fentanyl seized in the country comes through the Canadian border, with the overwhelming majority smuggled in from Mexico via the southern border. Mexico, which sends over 80% of its exports to the US , became America's top trading partner in 2023, largely driven by free trade between the two nations. Meanwhile, the European Union had initially aimed for a full-scale trade deal with the US but has since dialed back its ambitions. It is now pursuing a more flexible framework agreement, similar to the one struck with the UK, leaving finer details to be worked out over time. The EU faces internal tensions as Germany advocates for swift agreement to protect its industrial interests, whilst other members, including France, advise against accepting unfavourable US terms. Bernd Lange, who leads the European Parliament's trade committee, advised Brussels to implement counter-measures immediately. "This is a slap in the face for the negotiations. This is no way to deal with a key trading partner," Lange told Reuters. Trump's recent tariff directives have generated substantial revenue, with US customs duties exceeding $100 billion in the fiscal year through to June, according to US Treasury figures. These measures have affected diplomatic relations with close US allies. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now
Time of India
37 minutes ago
- Time of India
hiv vaccine: US aid cuts halt HIV vaccine research in South Africa, with global impact
ADVERTISEMENT ADVERTISEMENT ADVERTISEMENT Just a week had remained before scientists in South Africa were to begin clinical trials of an HIV vaccine , and hopes were high for another step toward limiting one of history's deadliest pandemics. Then the email all work, it said. The United States under the Trump administration was withdrawing all its news devastated the researchers, who live and work in a region where more people live with HIV than anywhere else in the world. Their research project, called BRILLIANT , was meant to be the latest to draw on the region's genetic diversity and deep expertise in the hope of benefiting people the $46 million from the U.S. for the project was disappearing, part of the dismantling of foreign aid by the world's biggest donor earlier this year as President Donald Trump announced a focus on priorities at Africa hit hard by aid cuts South Africa has been hit especially hard because of Trump's baseless claims about the targeting of the country's white Afrikaner minority. The country had been receiving about $400 million a year via USAID and the HIV-focused that's Grey, who heads the Brilliant program, said the African continent has been vital to the development of HIV medication, and the U.S. cuts threaten its capability to do such work in the advances have included clinical trials for lenacapavir, the world's only twice-a-year shot to prevent HIV, recently approved for use by the U.S. Food and Drug Administration. One study to show its efficacy involved young South Africans."We do the trials better, faster and cheaper than anywhere else in the world, and so without South Africa as part of these programs, the world, in my opinion, is much poorer," Gray noted that during the urgency of the COVID-19 pandemic , South Africa played a crucial role by testing the Johnson & Johnson and Novavax vaccines, and South African scientists' genomic surveillance led to the identification of an important empty and thousands are laid off A team of researchers at the University of the Witwatersrand has been part of the unit developing the HIV vaccines for the the Wits laboratory, technician Nozipho Mlotshwa was among the young people in white gowns working on samples, but she may soon be out of a position is grant-funded. She uses her salary to support her family and fund her studies in a country where youth unemployment hovers around 46%."It's very sad and devastating, honestly," she said of the U.S. cuts and overall uncertainty. "We'll also miss out collaborating with other scientists across the continent."Professor Abdullah Ely leads the team of researchers. He said the work had promising results indicating that the vaccines were producing an immune now that momentum, he said, has "all kind of had to come to a halt."The BRILLIANT program is scrambling to find money to save the project. The purchase of key equipment has stopped. South Africa's health department says about 100 researchers for that program and others related to HIV have been laid off. Funding for postdoctoral students involved in experiments for the projects is at Africa's government has estimated that universities and science councils could lose about $107 million in U.S. research funding over the next five years due to the aid cuts, which affect not only work on HIV but also tuberculosis - another disease with a high number of cases in the money, and less data on what's affected South Africa's government has said it will be very difficult to find funding to replace the U.S. now the number of HIV infections will grow. Medication is more difficult to obtain. At least 8,000 health workers in South Africa's HIV program have already been laid off, the government has said. Also gone are the data collectors who tracked patients and their care, as well as HIV counselors who could reach vulnerable patients in rural researchers, Universities South Africa, an umbrella body, has applied to the national treasury for over $110 million for projects at some of the largest a visit to South Africa in June, UNAIDS executive director Winnie Byanyima was well aware of the stakes, and the lives at risk, as research and health care struggle in South Africa and across Africa at countries that were highly dependent on U.S. funding including Zambia, Nigeria, Burundi and Ivory Coast are already increasing their own resources, she said."But let's be clear, what they are putting down will not be funding in the same way that the American resources were funding," Byanyima said.
